Billings Clinic
Especially For:

Clinical Trials

Title   Type 2 Diabetes (BCB109)
Description   A Randomized, Placebo-controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus
IRB Number   BCB109 - EXSCEL
Category   Diabetes
Inclusion/Notes   Patients eligible for participation must be:
* Type 2 diabetes with an HbA1c of = 7.0% and = 10.0% on stable doses of up to three oral AHAs for at least 3 months
* Patients with any level of CV risk including: history of ischemic stroke, a major clinical manifestation of coronary artery disease, myocardial infarction, surgical or percutaneous coronary revascularization procedure or coronary angiography showing at least one stenosis > 50% in a major epicardial artery or branch vessel
* Patients can also have had a history of carotid arterial disease or atherosclerotic peripheral arterial disease.
Status   Actively Recruiting
Start Date   12/28/2010
Principal Investigator (PI)   Christopher Sorli, MD
Physician Profile   Christopher H Sorli, MD
Contact Name   Recruitment Hotline
Contact Email   Research Department
Phone   (406) 657-4111
Alternate Phone   (800) 996-2663
Fax   (406) 247-6512
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.